Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is the most common progressive neurodegenerative disease worldwide, but its cause remains unclear. Although a few drugs can provide temporary and partial relief of symptoms in some patients, no curative treatment is available. Therefore, attention has been focused on research using stem cells to treat AD. Among stem cells, mesenchymal stem cells (MSCs) have been used to treat the related pathologies in animal models of AD, and other neurodegenerative disease. This review describes latest research trends on the use of MSC-based therapies in AD and its action of mechanism. MSCs have several beneficial effects. They would be specified as the reduction of neuroinflammation, the elimination of amyloid-β, neurofibrillary tangles, and abnormal protein degradation, the promotion of autophagy-associated and blood-brain barrier recoveries, the upregulation of acetylcholine levels, improved cognition, and the recovery of mitochondrial transport. Therefore, this review describes the latest research trends in MSC-based therapy for AD by demonstrating the importance of MSC-based therapy and understanding of its mechanisms in AD and discusses the limitations and perspectives of stem cell therapy in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Salem, A. M., Ahmed, H. H., Atta, H. M., Ghazy, M. A., & Aglan, H. A. (2014) · Cell Biology International · doi:10.1002/cbin.10331 · Cited by 56 · cited 1×
“In an AD rat model with hippocampal A (cid:2) lesions, a single intravenous injection of BM-MSCs resulted in the complete elimination of A (cid:2) [38].”
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Under normal conditions, autophagy plays an important role in maintaining cellular homeostasis by breaking down unnecessary or abnormal cellular components; however, dysfunctions in autophagy are associated with cancer, inflammatory, and neurodegenerative diseases [43, 44].”
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511 · cited 1×
“Fourth, MSCs are rarely immunogenic as they do not express MHC class II or co-stimulatory molecules (CD80, CD86, or CD40) [17], as well as suppress the activations and proliferations of T and B lymphocytes [18–20], and the differentiations and maturations of dendritic cells [21, 22].”
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · cited 2×
“BBB breakdown leads to accumulation of neurotoxic materials and the activations of astrocytes and microglia and inflammatory response [49], leading to accumulation of the fibrous scraps of cells such as pericyte and endothelial cells, which make drug absorption or therapeutic delivery to the brain…”
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 1×
“Under normal conditions, autophagy plays an important role in maintaining cellular homeostasis by breaking down unnecessary or abnormal cellular components; however, dysfunctions in autophagy are associated with cancer, inflammatory, and neurodegenerative diseases [43, 44].”
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
Research works printed but not linked: 1
- Alzheimer’s Disease International, 2019, World Alzheimer Report 2019. Attitudes to dementia.
Cited by
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
“Nonetheless, a small number of preclinical investigations have demonstrated advancements in the modelling of AD pathology utilizing ESCs (Kim et al., 2020a).”
BackgroundInfluentialSafiri, S., Ghaffari Jolfayi, A., Fazlollahi, A., Morsali, S., Sarkesh, A., Daei Sorkhabi, A., Golabi, B., Aletaha, R., Motlagh Asghari, K., Hamidi, S., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1474043 · Cited by 200
Sha, S., Shen, X., Cao, Y., & Qu, L. (2021) · Aging · doi:10.18632/aging.203088 · Cited by 107
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Zhang, F., Zhong, R.-J., Cheng, C., Li, S., & Le, W.-D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00565-5 · Cited by 105
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94
“Second, they are less prone to transformation into neoplastic cells [169].”
Background
Metadata
- Authors
- Kim, J., Lee, Y., Lee, S., Kim, K., Song, M., & Lee, J.
- Affiliations
- Department of Pharmacy, College of Pharmacy, Pusan National University, Busan, Republic of Korea
- Korea Brain Research Institute (KR)
- Pusan National University (KR)
- University of Cambridge (GB)
- Corresponding author
- Song, Minjung
- Lee, Jaewon
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-09-01
- Volume
- 77
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W3046677722
- Cited by
- 73
- References
- 96
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 20 · 2023: 24 · 2022: 8 · 2021: 9 · 2020: 1
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- mesenchymal stem cells, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Forecasting, Humans, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives. https://app.cochat.ai/papers/10.3233/jad-200219
- The paper
- Kim, J., Lee, Y., Lee, S., Kim, K., Song, M., & Lee, J. (2020). Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-200219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.